CMS cancels Medicare pilot offering GLP-1s to seniors at discount
WASHINGTON — The Trump administration had planned for insurers to provide cheap weight loss drugs to seniors through…
Eli Lilly’s $3.25B acquisition of Kelonia Therapeutics caps startup’s tortuous ride
Eli Lilly is spending $3.25 billion to acquire Kelonia Therapeutics, a small biotech company developing cell therapies for…
Lilly’s Foundayo hits 1,390 prescriptions in debut week
April 17 (Reuters) – Eli Lilly’s newly launched obesity pill was prescribed 1,390 times in the U.S. as…
After Obtaining Approval for Its Weight Loss Pill, Is It Off to the Races for Eli Lilly Stock?
On April 1, Eli Lilly (NYSE: LLY) and its shareholders received the news they were eagerly awaiting: the…
Eli Lilly Weight-Loss Pill Becomes Available in U.S.
Eli Lilly’s Foundayo weight-loss pill is now available in the U.S. following the Food and Drug Administration’s approval…
Americans want weight-loss pills for cost and convenience
By Leah Douglas WASHINGTON, April 6 (Reuters) – Americans starting weight-loss medicines for the first time want lower…
Global drug makers face pricing pressure as China targets affordable healthcare
Global pharmaceutical companies posted mixed earnings in China last year, with some firms warning that 2026 will be…
FDA approves Eli Lilly’s new weight loss pill with no food restrictions
The Food and Drug Administration approved Eli Lilly’s new oral weight loss drug Foundayo, the company said Wednesday,…
Trump unveils 100% tariff that could hit some patented drugs this year
NEW YORK (AP) — President Donald Trump signed an executive order Thursday that could slap long-threatened pharmaceutical tariffs…
Asian stocks jump on renewed hopes of Iran war ending
HONG KONG (AP) — Asian shares were sharply higher Wednesday after U.S. stocks soared to their best day…
Eli Lilly and Insilico Medicine forge $2.75bn AI-driven R&D pact
Eli Lilly is joining forces with artificial intelligence (AI)-powered biotech, Insilico Medicine, in a drug discovery and development…
Ozempic Goes Generic —But Not in the US
A drug that helped turn Novo Nordisk into Europe’s most valuable company is about to lose its…